SLDB 外汇新闻
Solid Biosciences Says FDA Grants Fast Track Designation For Gene Therapy Candidate SGT-003
Life sciences company Solid Biosciences Inc. (SLDB) announced Thursday that it has received Fast Track Designation from the U.S. Food and Drug Administration (FDA) for SGT-003, the company's next-generation Duchenne muscular dystrophy gene therapy candidate.
RTTNews
|
427天前
Solid Biosciences Appoints Kevin Tan As New CFO
Life sciences company Solid Biosciences Inc. (SLDB) announced Monday the appointment of Kevin Tan, a seasoned industry professional, as Chief Financial Officer.
RTTNews
|
759天前
